Top Section/Ad
Top Section/Ad
Most recent
Military goggles maker Theon starts €150m rights issue
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Bayer and Monsanto are circling each other as they both seek acceptable terms for a merger that would create a world leader in crop science. For the equity capital markets, the deal holds out the possibility of one of the world’s largest ever rights issues. -
Thailand’s Berli Jucker is planning to raise up to Bt214bn ($6.0bn) by issuing fresh equity and selling new bonds, in a bid to pay off debt used for its acquisition of hypermarket operator Big C Supercenter, according to a statement on Thursday.
-
A lacklustre year for equity capital markets suddenly grew more interesting on Monday, when Bayer announced the details of a $62bn bid for Monsanto. It got still more interesting on Tuesday, when the US agribusiness group rejected the offer as “incomplete and financially inadequate”.
-
Indonesia’s Bank Permata is planning to raise Rph5.5tr ($403.4m) from a rights issue next month, having received the go ahead from the country’s financial regulator, according to a press release from the firm.
-
Monsanto has rejected Bayer’s all-cash bid of a $62bn enterprise value as “incomplete and financially inadequate”, but left the door open to an improved offer.
-
Indonesia’s Medco Energi Internasional is planning a rights issue to raise Rph4.66tr ($349.59m), in a deal that could increase its share base by almost half, according to a company filing.
